TaNeDS (Take a New Challenge for Drug diScovery) is Daiichi Sankyo’s open competition grant program.
The goal of this program is to generate breakthrough pharmaceutical drugs for human health by promoting new drug discovery themes, R&D technologies, and continuous collaboration with external researchers and research groups.
In 2019, this program will cover the European area and all across the United States. We set two sizes of the grant, up to €/$ 75,000 per year (Type A) for discovery stage and up to €/$150,000 per year (Type B) for validation stage.
One key goal of TaNeDS Global is to foster close collaborative relationships between principal investigators of the funded projects and scientists at Daiichi Sankyo. Collaboration beyond the initial funding period is also possible for successful projects to fulfill our ultimate goal of drug development.
2. Pain / Neuroscience
3. Cardiovascular and renal diseases
4. Rare diseases
5. Other diseases
6. Cell therapy
7. Technology and related research
Deadline: 15th February 2019.
Per maggiori informazioni https://www.unibs.it/ricerca/finanziamenti-la-ricerca/finanziamenti-internazionali/finanziamenti-extra-europei/daiichi-sankyo/taneds-take-new-challenge-drug-discovery